AHA advisory endorses EVT for large-core ischemic stroke
UC expert comments on new recommendations to Medscape
The University of Cincinnati's Pooja Khatri spoke with Medscape on a new American Heart Association advisory recommending endovascular therapy (EVT) as a treatment for patients with large-core ischemic strokes.
The advisory was published Dec. 17 in the journal Stroke, and Khatri was a coauthor.
EVT is a minimally invasive procedure for acute ischemic stroke patients that uses a catheter to remove a clot from a blood vessel in the brain, which restores blood flow. Patients with strokes with a large ischemic core were previously not considered candidates for EVT because of concerns of an increased risk of hemorrhage, disability and death, but six recent trials provided evidence of its benefit.
“These trials provide new data to suggest that selected patients with ischemic stroke due to large vessel occlusions should be treated with EVT,” Khatri, MD, vice chair of research and division chief in the Department of Neurology and Rehabilitation Medicine at UC's College of Medicine; associate director of the UC Gardner Neuroscience Institute; and codirector of NIH StrokeNet’s National Coordinating Center, told Medscape.
“These findings ran counter to prior thinking and guidelines, so we wanted to bring this important treatment opportunity to the attention of practicing clinicians," she added.
Featured photo at top of illustration of brain with stroke symptoms. Photo/PeterSchreiber.media/iStock.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.